Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Cruz

Showing results (31-40 of 433) with videos related to

Pageof 44
Sort By:
Pediatrics|March 18, 2020
COVID-19 in Children: Initial Characterization of the Pediatric DiseaseAndrea T Cruz, Steven L Zeichner
Clinical Pediatrics|December 25, 2013
Relationship between tuberculin skin test (TST) size and interferon gamma release assay (IGRA) result: when should clinicians obtain IGRAs in children with positive TSTs?Andrea T Cruz, Jeffrey R Starke
Current Opinion in Infectious Diseases|August 10, 2022
Childhood tuberculosisLindsay H Cameron, Andrea T Cruz
Pediatrics|March 18, 2022
Integrating SARS-CoV-2 Antibody Results in Children Into Pandemic ResponseAndrea T Cruz, Mark R Denison
Paediatric Respiratory Reviews|June 19, 2007
Clinical manifestations of tuberculosis in childrenAndrea T Cruz, Jeffrey R Starke
Tuberculosis (Edinburgh, Scotland)|November 15, 2011
A current review of infection control for childhood tuberculosisAndrea T Cruz, Jeffrey R Starke
Pediatrics|December 16, 2018
Uncounted Deaths: Estimating Postdischarge Pediatric MortalityMarideth C Rus, Andrea T Cruz
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 6, 2014
Safety and completion of a 4-month course of rifampicin for latent tuberculous infection in childrenA T Cruz, J R Starke
Emerging Infectious Diseases|February 22, 2019
Window Period Prophylaxis for Children Exposed to Tuberculosis, Houston, Texas, USA, 2007-2017Andrea T Cruz, Jeffrey R Starke
Indian Journal of Pediatrics|March 1, 2019
Monitoring Treatment of Childhood Tuberculosis and the Role of Therapeutic Drug MonitoringAndrea T Cruz, Jeffrey R Starke
Pageof 44

Showing results (31-40 of 433) with videos related to

Sort By:
Pageof 44
Pediatrics|March 18, 2020
COVID-19 in Children: Initial Characterization of the Pediatric DiseaseAndrea T Cruz, Steven L Zeichner
Clinical Pediatrics|December 25, 2013
Relationship between tuberculin skin test (TST) size and interferon gamma release assay (IGRA) result: when should clinicians obtain IGRAs in children with positive TSTs?Andrea T Cruz, Jeffrey R Starke
Current Opinion in Infectious Diseases|August 10, 2022
Childhood tuberculosisLindsay H Cameron, Andrea T Cruz
Pediatrics|March 18, 2022
Integrating SARS-CoV-2 Antibody Results in Children Into Pandemic ResponseAndrea T Cruz, Mark R Denison
Paediatric Respiratory Reviews|June 19, 2007
Clinical manifestations of tuberculosis in childrenAndrea T Cruz, Jeffrey R Starke
Tuberculosis (Edinburgh, Scotland)|November 15, 2011
A current review of infection control for childhood tuberculosisAndrea T Cruz, Jeffrey R Starke
Pediatrics|December 16, 2018
Uncounted Deaths: Estimating Postdischarge Pediatric MortalityMarideth C Rus, Andrea T Cruz
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 6, 2014
Safety and completion of a 4-month course of rifampicin for latent tuberculous infection in childrenA T Cruz, J R Starke
Emerging Infectious Diseases|February 22, 2019
Window Period Prophylaxis for Children Exposed to Tuberculosis, Houston, Texas, USA, 2007-2017Andrea T Cruz, Jeffrey R Starke
Indian Journal of Pediatrics|March 1, 2019
Monitoring Treatment of Childhood Tuberculosis and the Role of Therapeutic Drug MonitoringAndrea T Cruz, Jeffrey R Starke
Pageof 44